Kumar et al., 2022 - Google Patents
Is regular probiotic practice safe for management of sepsis?Kumar et al., 2022
View PDF- Document ID
- 13784600676004996220
- Author
- Kumar R
- Tripathi A
- Sharma N
- Singh G
- Mohapatra L
- Publication year
- Publication venue
- Chinese journal of integrative medicine
External Links
Snippet
For decades, the gut has been thought to play an important role in sepsis pathogenesis. Sepsis is a serious life-threatening, chronic condition of an infection caused by dysregulated host immune response in most of the intensive care unit patients. Probiotics have dual roles …
- 230000000529 probiotic 0 title abstract description 89
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| You et al. | The promotion mechanism of prebiotics for probiotics: A review | |
| Liu et al. | Probiotics in disease prevention and treatment | |
| Capurso | Thirty years of Lactobacillus rhamnosus GG: a review | |
| Wang et al. | Protective effects of different Bacteroides vulgatus strains against lipopolysaccharide-induced acute intestinal injury, and their underlying functional genes | |
| Pandey et al. | Probiotics, prebiotics and synbiotics-a review | |
| Yang et al. | The impact of dietary fiber and probiotics in infectious diseases | |
| Armstrong et al. | Not all fibers are born equal; variable response to dietary fiber subtypes in IBD | |
| CN108430483B (en) | Therapeutic microbiota for the treatment and/or prevention of food allergy | |
| Lin et al. | Impact of the gut microbiota, prebiotics, and probiotics on human health and disease | |
| US10286001B2 (en) | Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics | |
| Cheng et al. | The bidirectional relationship between host physiology and microbiota and health benefits of probiotics: A review | |
| Klaenhammer et al. | The impact of probiotics and prebiotics on the immune system | |
| Haque et al. | The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms–an appraisal | |
| Vieira et al. | The role of probiotics and prebiotics in inducing gut immunity | |
| JP5905032B2 (en) | Synbiotic composition for recovery and reconstitution of intestinal microbiota | |
| Rupa et al. | Recent advances in the role of probiotics in human inflammation and gut health | |
| Hajela et al. | Gut microbiome, gut function, and probiotics: Implications for health | |
| Vandenplas et al. | Probiotics and prebiotics in infants and children | |
| Ozma et al. | Postbiotics as the key mediators of the gut microbiota-host interactions | |
| JP6527522B2 (en) | Nutritional composition for reducing enteric pathogens | |
| Kumar et al. | Is regular probiotic practice safe for management of sepsis? | |
| Gorreja et al. | The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies | |
| Yang et al. | Precise strategies for selecting probiotic bacteria in treatment of intestinal bacterial dysfunctional diseases | |
| Strain et al. | Effect of diet on pathogen performance in the microbiome | |
| Peng et al. | Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms |